Beltapharm SPA DMF, CEP, Written Confirmations, FDF, Prices, Patents, Patents & Exclusivities, Dossier, Manufacturer, Licensing, Distributer, Suppliers, News, GMP

Merck, Eisai End Keytruda-Lenvima Collaboration In Liver Cancer

30 Oct 2025

// FIERCE PHARMA

Regeneron Pledges $1B+ For Modex Multispecific Antibodies

30 Oct 2025

// FIERCE BIOTECH

Sk Pharmteco, Lotte Biologics Partner to Enhance Global ADC CDMO

30 Oct 2025

// BUSINESSWIRE

DATA COMPILATION
#PharmaFlow

Contact Supplier

Website

SupplySide West

Not Confirmed

Book a meeting

envelop Contact Supplier

REF. STANDARDS & IMPURITIES

1 Others

otherProducts
1 Others

INSPECTIONS & REGISTRATIONS

3 FDA, 1 EDQM, 1 GDUFA

inspections
3 FDA
1 EDQM
1 GDUFA

About

BELTAPHARM S.p.A. was started in 1982 by a team of entrepreneurs with experience in the pharmaceutical field. Its scope is the production by contract manufacturing of pharmaceuticals for human. These are produced in the commonest pharmaceutical forms, mainly as generics (ex galenics), for export outside Europe (Africa, Asia and Latin America). Beltapharm S.p.A is approved as third-party manufacturer by several Italian and European companies for the production of pharmaceuticals in liquid and semi-solid forms, with a particular emphasis on steroid-based products like: cream,ointments and gels, both for human and veterinary use.